- BNY Mellon and its clearing house Pershing Securities had restricted the securities.
- The restriction resulted in non-acceptance of MXC securities along with other cannabis businesses.
- The list also included Australian listed cannabis companies.
- Securities of MGC Pharma were permitted for trading from 30 November 2019 after a review.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.